YPR059C Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to YPR059C Antibody

YPR059C Antibody (Product Code: CSB-PA314370XA01SVG) is a polyclonal antibody generated against the YPR059C protein, a hypothetical ORF in S. cerevisiae. This antibody is primarily utilized in molecular biology to study yeast gene expression, protein localization, and functional genomics. It is produced via recombinant methods, ensuring high specificity and reproducibility .

Antigen Specificity

  • Target Protein: YPR059C (UniProt ID: P0C5E1)

  • Host Species: Rabbit

  • Isotype: IgG

  • Immunogen: Synthetic peptide derived from the YPR059C protein sequence .

Antibody Structure

Like all IgG antibodies, YPR059C Antibody comprises:

  • Fab region: Binds specifically to YPR059C epitopes.

  • Fc region: Mediates immune effector functions (e.g., complement activation) .
    Post-translational glycosylation in the Fc region influences stability and binding to Fc receptors .

Research Applications

YPR059C Antibody is widely used in:

  1. Western Blot (WB): Detects YPR059C expression in yeast lysates .

  2. Immunoprecipitation (IP): Isolates YPR059C-protein complexes for interactome studies .

  3. ELISA: Quantifies YPR059C levels in experimental samples .

Example Protocol

ApplicationDilutionSample Type
Western Blot1:200–1:1000S. cerevisiae lysate
Immunoprecipitation0.5–4.0 µg per 1–3 mg lysateYeast protein extract

Comparative Analysis

YPR059C Antibody shares production workflows with recombinant antibodies described in therapeutic research, such as codon optimization and protein A purification .

Significance in Scientific Research

  • Genomic Annotation: Facilitates functional studies of poorly characterized yeast genes .

  • Tool Development: Serves as a control in antibody validation pipelines, akin to Rabbit IgG controls .

  • Therapeutic Analogues: Methods used to produce YPR059C Antibody mirror those for clinical antibodies (e.g., anti-PF4 antibodies in VITT studies) .

Future Directions

  1. CRISPR/Cas9 Validation: Confirm YPR059C knockout phenotypes using antibody-based detection .

  2. Structural Studies: Resolve YPR059C’s 3D structure via cryo-EM, leveraging antibody-antigen complexes .

  3. Cross-Species Analysis: Test cross-reactivity with orthologs in pathogenic fungi .

References

  1. Spiegelberg, H. L. (1989). Fc receptors. Immunology Today.

  2. GENEWIZ. (2025). Recombinant Antibody Production.

  3. Cusabio. (2025). YPR059C Antibody Specifications.

  4. AbDb. (2018). Antibody Structure Database.

  5. Thiele et al. (2021). Deglycosylated Anti-PF4 Antibodies.

  6. Wikipedia. (2001). Antibody Structure and Function.

  7. Proteintech. (2025). Rabbit IgG Control Antibody.

  8. Abanades et al. (2023). PLAbDab Antibody Database.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YPR059CPutative uncharacterized protein YPR059C antibody
Target Names
YPR059C
Uniprot No.

Q&A

Basic Research Questions

  • What is YPR059C and what experimental applications require antibodies against it?

    YPR059C is a yeast gene that contains an upstream open reading frame (uORF) that acts as a weak repressor . It has been identified in studies related to oxidative stress tolerance pathways . When developing experimental approaches to study this gene, researchers should consider:

    • ChIP analysis: YPR059C has been studied using chromatin immunoprecipitation with specific antibodies to analyze its genomic associations

    • Expression studies: Antibodies enable quantification of protein levels under different conditions

    • Localization analysis: Determine subcellular distribution using immunofluorescence

    • Interaction studies: Identify binding partners through co-immunoprecipitation

    • Functional analysis: Investigate its role in stress response mechanisms, particularly oxidative stress

  • What experimental techniques are most effective with YPR059C antibodies?

    Several techniques yield robust results with YPR059C antibodies:

    TechniqueSample PreparationAntibody DilutionKey ControlsAnalysis Method
    ChIPCrosslink cells with 1% formaldehyde, sonicate chromatin2-5 μg per IPInput DNA, IgG control, YPR059C deletion strainqPCR or sequencing
    Western BlotStandard SDS-PAGE with yeast whole cell extract1:500-1:2000YPR059C deletion strain, tagged YPR059C strainDensitometry
    Immunofluorescence3.7% formaldehyde fixation, spheroplasting1:100-1:500Secondary-only, YPR059C deletion strainConfocal microscopy
    Flow CytometrySurface display on yeast, labeling with fluorophore-conjugated antibodies1:50-1:200Unstained cells, isotype controlMean fluorescence intensity

    For ChIP applications, follow established protocols for Saccharomyces cerevisiae that typically involve formaldehyde crosslinking, cell lysis, chromatin sonication, immunoprecipitation, and analysis by qPCR or sequencing .

  • How should researchers validate YPR059C antibodies before experimental use?

    A systematic validation approach involves:

    Step 1: Genetic validation

    • Test antibody in wild-type vs. YPR059C deletion strains

    • Expected outcome: Signal present in wild-type, absent in deletion strain

    Step 2: Epitope verification

    • Test with tagged YPR059C (e.g., FLAG-YPR059C)

    • Compare signal pattern between anti-YPR059C and anti-tag antibodies

    • Expected outcome: Co-localization confirms epitope specificity

    Step 3: Application-specific validation

    • For Western blot: Confirm single band of expected molecular weight

    • For immunoprecipitation: Mass spectrometry verification of pulled-down protein

    • For ChIP: Enrichment at expected genomic regions

    Step 4: Cross-reactivity assessment

    • Test against closely related yeast proteins

    • Peptide competition assays to confirm specificity

Experimental Design Questions

  • How should I design a ChIP experiment to study YPR059C binding to genomic regions?

    Based on established chromatin immunoprecipitation protocols for yeast , implement the following workflow:

    Experimental setup:

    1. Culture preparation: Grow yeast to mid-log phase (5×10^6 cells/ml) in appropriate media

    2. Crosslinking: Add formaldehyde to 1% final concentration and incubate for 15-20 minutes

    3. Quenching: Add glycine to 125mM final concentration

    4. Cell harvesting: Centrifuge and wash cell pellets

    5. Cell lysis: Use glass beads or enzymatic methods optimized for yeast

    6. Chromatin fragmentation: Sonicate to achieve 200-500bp fragments

    7. Immunoprecipitation: Incubate fragmented chromatin with YPR059C antibody

    8. Washing: Remove non-specific interactions with increasingly stringent buffers

    9. Elution and reversal of crosslinks: Typically 65°C overnight treatment

    10. DNA purification: Column-based methods for optimal recovery

    11. Analysis: qPCR targeting regions of interest or genome-wide sequencing

    Critical optimization parameters:

    • Antibody amount: Titrate from 1-10μg per IP reaction to determine optimal concentration

    • Washing stringency: Balance between reducing background and maintaining specific interactions

    • Sonication conditions: Optimize time and power settings for your specific sonicator model

  • What are the essential controls when investigating YPR059C under different cellular stresses?

    When studying YPR059C's role in stress response pathways, particularly oxidative stress , incorporate these controls:

    Genetic controls:

    • YPR059C deletion strain: Confirms antibody specificity and provides negative control

    • YPR059C overexpression strain: Demonstrates signal correlation with protein abundance

    • Tagged YPR059C strain: Allows correlation between target antibody and tag-specific antibody

    Treatment controls:

    • Dose response: Multiple concentrations of stressor (e.g., H₂O₂ for oxidative stress)

    • Time course: Capture dynamic changes in YPR059C response

    • Recovery phase: Monitor return to baseline after stress removal

    Technical controls:

    • Loading controls: Antibodies against constitutively expressed proteins

    • Secondary antibody-only: Detects non-specific binding of detection system

    • Isotype control: Primary antibody of same isotype but irrelevant specificity

    Data analysis controls:

    • Biological replicates: Minimum of three independent experiments

    • Technical replicates: Multiple measurements within each biological replicate

    • Normalization methods: Account for variations in cell number and protein content

  • How can I optimize yeast transformation protocols when creating strains for YPR059C antibody studies?

    When generating yeast strains for YPR059C antibody validation or functional studies, optimize the transformation protocol as follows :

    Pre-transformation preparation:

    1. Culture cells to mid-log phase (OD₆₀₀ = 0.6-0.8)

    2. Prepare competent cells using lithium acetate method

    3. Use high-quality plasmid DNA or PCR products with sufficient homology arms

    Transformation procedure:

    1. Centrifuge competent cells at 5000×g for 2 minutes

    2. Add transformation mix (360μL) containing DNA, carrier DNA, PEG, and lithium acetate

    3. Heat shock at 42°C for 40 minutes (this extended time is optimal for yeast)

    4. Recover cells in YPD medium for 1.5 hours at 30°C

    5. Plate on selective media and incubate for 3 days at 30°C

    Optimization strategies:

    • Adjust DNA amount: Test 100ng-1μg range

    • Modify heat shock duration: 30-45 minutes depending on strain sensitivity

    • Vary PEG concentration: 35-45% for optimal balance of efficiency and cell viability

    Verification methods for YPR059C modification:

    • PCR verification of genomic modifications

    • Western blot with YPR059C antibodies to confirm altered expression

    • Functional assays to assess phenotypic changes

Data Analysis Questions

  • How should I interpret contradictory results from different YPR059C antibodies in ChIP experiments?

    When faced with discrepancies between antibodies targeting YPR059C, implement this systematic troubleshooting approach:

    Step 1: Antibody characterization comparison

    • Epitope location: Different antibodies may target distinct regions of YPR059C

    • Clonality: Monoclonal antibodies target single epitopes while polyclonals recognize multiple sites

    • Production methods: Different immunization strategies can affect specificity

    Step 2: Experimental validation

    • Peptide competition assay: Pre-incubate antibodies with immunizing peptide

    • YPR059C deletion strain: Test both antibodies against knockout control

    • Tagged YPR059C: Compare antibody signals with anti-tag antibody signal

    Step 3: Technical consideration matrix

    FactorPotential ImpactResolution Approach
    Fixation methodMay affect epitope accessibilityTest multiple fixation protocols
    Chromatin fragmentationInfluences epitope exposureOptimize sonication conditions
    Buffer compositionAffects antibody binding affinityTest different IP buffers
    Washing stringencyChanges signal-to-noise ratioPerform titration of wash buffer stringency
    CrossreactivityNon-specific binding to related proteinsPerform immunoprecipitation followed by mass spectrometry

    Step 4: Biological context analysis

    • Consider post-translational modifications that might affect epitope recognition

    • Evaluate protein complex formation that could mask certain epitopes

    • Assess potential alternative splice variants or protein isoforms

  • What statistical approaches should be applied when analyzing ChIP-seq data for YPR059C binding sites?

    A robust statistical framework for ChIP-seq data analysis includes:

    Quality control and preprocessing:

    1. Read quality assessment: Filter low-quality sequences (PHRED score <20)

    2. Adapter trimming: Remove sequencing adapters

    3. Alignment to reference genome: Use S. cerevisiae genome (recommend Bowtie2 or BWA)

    4. PCR duplicate removal: Eliminate amplification artifacts

    5. Fragment size distribution analysis: Verify successful chromatin fragmentation

    Peak calling and identification:

    1. Peak detection: Use MACS2 with p-value threshold of 10^-5

    2. Signal normalization: Apply methods like RPKM or TMM

    3. Background correction: Use input DNA or IgG control samples

    4. False discovery rate control: Apply Benjamini-Hochberg correction

    Differential binding analysis:

    1. For condition comparisons: Use DiffBind or MAnorm packages

    2. Normalize for sequencing depth differences

    3. Apply fold-change thresholds (typically >2-fold) and statistical significance cutoffs (p<0.05)

    Functional analysis:

    1. Genomic feature association: Determine binding patterns relative to genes

    2. Motif analysis: Identify DNA sequence preferences

    3. Integration with gene expression: Correlate binding with transcriptional changes

    4. Pathway enrichment: Connect targets to biological processes

  • How can I distinguish between signal artifacts and genuine YPR059C binding in immunolocalization studies?

    To discriminate between true signals and artifacts in YPR059C localization studies:

    Experimental approaches:

    1. Specificity controls

      • Pre-immune serum comparison: Should show minimal background

      • YPR059C deletion strain: Should show no specific signal

      • Antibody pre-absorption: Pre-incubate with purified antigen to block specific binding

    2. Sample preparation controls

      • Compare different fixation methods: Formaldehyde, methanol, etc.

      • Test various permeabilization protocols: Optimize for YPR059C accessibility

      • Implement antigen retrieval techniques if necessary

    3. Imaging controls

      • Z-stack acquisition: Distinguish true signal from focal plane artifacts

      • Spectral controls: Verify fluorophore emission spectra to eliminate bleed-through

      • Multiple exposure settings: Determine detection threshold optimization

    Quantitative validation:

    1. Signal quantification across multiple cells (n>30)

    2. Statistical comparison between experimental and control samples

    3. Correlation with orthogonal methods (e.g., fractionation studies, tagged proteins)

    4. Co-localization analysis with known cellular markers

Advanced Research Questions

  • How can YPR059C antibodies be used to investigate its role in oxidative stress response pathways?

    YPR059C has been implicated in oxidative stress tolerance , and antibodies enable several advanced investigation approaches:

    Dynamic expression profiling:

    1. Subject yeast to oxidative stressors (H₂O₂, menadione, paraquat)

    2. Collect time-course samples (5, 15, 30, 60, 120 min post-exposure)

    3. Perform Western blot analysis with YPR059C antibodies

    4. Quantify protein level changes relative to stress intensity and duration

    Stress-dependent localization:

    1. Perform immunofluorescence using YPR059C antibodies before and after oxidative stress

    2. Co-stain with organelle markers (mitochondria, nucleus, ER)

    3. Quantify potential translocation events using image analysis software

    4. Compare wild-type localization with mutants defective in stress response pathways

    Protein interaction dynamics:

    1. Perform co-immunoprecipitation with YPR059C antibodies under normal and stress conditions

    2. Identify stress-specific interaction partners using mass spectrometry

    3. Validate key interactions using reciprocal co-IP or proximity ligation assays

    4. Map interaction changes to specific stress response phases

    Chromatin association patterns:

    1. Conduct ChIP-seq with YPR059C antibodies under varying stress conditions

    2. Identify condition-specific genomic binding sites

    3. Correlate with transcriptional changes of associated genes

    4. Integrate with binding data for known stress-response transcription factors

  • What methodologies can resolve contradictions between YPR059C antibody studies and uORF functional analysis?

    Research has shown that YPR059C contains a uORF (upstream Open Reading Frame) that acts as a weak repressor . When antibody studies produce results contradicting uORF functional data:

    Integration of protein and transcript analysis:

    1. Perform parallel quantification of:

      • YPR059C protein using validated antibodies (Western blot)

      • YPR059C mRNA using RT-qPCR

      • uORF translation using ribosome profiling

    2. Calculate protein-to-mRNA ratios to identify translational regulation

    3. Correlate uORF usage with main ORF translation efficiency

    Mutational analysis approach:

    1. Generate constructs with modified uORF sequences:

      • uORF-eliminated variants

      • uORF start codon mutants

      • uORF-main ORF distance variants

    2. Compare expression levels using YPR059C antibodies

    3. Perform polysome profiling to assess translational efficiency

    4. Correlate with reporter assays measuring functional output

    Spatial organization analysis:

    1. Use antibodies recognizing different YPR059C epitopes to determine:

      • Full-length protein localization

      • Potential truncated protein products

      • Alternative translation start site usage

    2. Compare with fluorescent reporter constructs containing uORF modifications

    3. Assess co-localization patterns with translation machinery components

    Temporal dynamics investigation:

    1. Study the kinetics of YPR059C expression after transcriptional activation

    2. Compare timing of mRNA production, uORF translation, and main ORF translation

    3. Correlate with changes in cellular physiology using functional assays

  • How can advanced ChIP-seq analysis with YPR059C antibodies inform gene regulatory network modeling?

    Using YPR059C antibodies for ChIP-seq enables sophisticated regulatory network analysis:

    Integrative genomics workflow:

    1. Perform high-resolution ChIP-seq with optimized antibody conditions

      • Use spike-in normalization for quantitative comparisons

      • Generate biological triplicates for statistical robustness

      • Include input controls and YPR059C deletion controls

    2. Execute multi-modal data integration

      • Correlate binding sites with RNA-seq expression data

      • Overlay with chromatin accessibility data (ATAC-seq)

      • Integrate with histone modification patterns (H3K4me3, H3K27ac)

    3. Apply network inference algorithms

      • Identify direct YPR059C regulatory targets

      • Distinguish activating vs. repressive interactions

      • Determine feedback and feed-forward loops

    4. Validate key regulatory connections

      • Perform reporter assays with YPR059C binding site mutations

      • Use CRISPRi to target YPR059C binding regions

      • Measure expression changes in YPR059C mutants

    Analysis of binding dynamics across conditions:

    ConditionBinding Site DistributionMotif EnrichmentCo-factorsBiological Function
    Normal growthBaseline genome-wide mappingPrimary motif identificationConstitutive partnersHomeostatic regulation
    Oxidative stressStress-specific target acquisitionSecondary motifsStress-induced partnersAdaptive response
    Nutrient limitationMetabolic gene targetingCondition-specific motifsMetabolic regulatorsResource allocation
    Cell cycle phasesPhase-specific binding patternsCell cycle motifsCyclins, CDKsCell division control

    This comprehensive approach enables construction of predictive models for YPR059C function within the broader gene regulatory network, particularly in the context of stress response mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.